Near‐Infrared Nano‐Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria

Xiaoqiang Zhu,Sihan Chen,Xiuwen Hu,Lijun Zhao,Yiqian Wang,Jinzhao Huang,Jiawen Chen,Yuzhi Qiu,Xuefei Zhang,Mengdie Wang,Xiangliang Yang,Yan Zhang,Yanhong Zhu
DOI: https://doi.org/10.1002/adma.202207198
IF: 29.4
2022-11-02
Advanced Materials
Abstract:Certain anaerobic microbes with the capability to colonize in tumor microenvironment tend to express the heterologous gene in a sustainable manner, which would inevitably comprise the therapeutic efficacy and induce off‐tumor toxicity in vivo. To improve the therapeutic precision and controllability of bacteria‐based therapeutics, Escherichia coli Nissle 1917 (EcN) engineered to sense blue light and release the encoded flagellin B (flaB), is conjugated with lanthanide upconversion nanoparticles (UCNPs) for near‐infrared (NIR) nano‐optogenetic cancer immunotherapy. Upon 808 nm photoirradiation, UCNPs emit at the blue region to photoactivate the EcN for secretion of flaB, which subsequently binds to Toll‐like receptor 5 expressed on the membrane of macrophages for activating immune response via MyD88‐dependent signal pathway. Such synergism leads to significant tumor regression in different tumor models and metastatic tumors with negligible side effects. Our studies based on NIR nano‐optogenetic platform highlight the rational of leveraging the optogenetic tools combined natural propensity of certain bacteria for cancer immunotherapy. This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?